Khee Wee Hau

Khee Wee Hau is currently Director & Chief Financial Officer at Yifan International since 2019, Director at SciGen (Australia) Pty Ltd. since 2020, Director at Evive Biotechnology Singapore Pte Ltd. since 2021, Member at Institute of Singapore Chartered Accountants, Chief Financial Officer at YSQ International Pte Ltd., and Chief Financial Officer & Secretary at Ellipsiz Ltd. starting 2025.
Former roles include Independent Non-Executive Director at AGV Group Ltd. in 2022, Director at Fullerton Health Global Doctors Pte Ltd., Keith Chan Musculoskelet & Family Medicine Centre Co., Ltd., Fullerton Health Clinic Hk Holdings Ltd., HMMP Medical Macau Ltd., Health Maintenance Medical Practice Ltd., Hmmp Dental Ltd., Hm Investment Holdings Ltd., FHHK Aurum Ltd., Tony Chun Kit Lee Medical Practice Ltd., T.H.E.
Fullerton Healthcare Group, S.C.
Fullerton Healthcare Group Ltd., Aurum Holdings, Washington Health Analytics Ltd., Evive Biotechnology Singapore Pte Ltd., Health Maintenance Management Services Ltd., Lead Independent Director at China Kunda Technology Holdings Ltd. from 2019 to 2024, Independent Non-Executive Director at Imperium Crown Ltd. from 2017 to 2025, Chief Financial Officer & Director at SciGen Pte Ltd. from 2021 to 2022, Finance Director & Director at go Game Pte Ltd. from 2018 to 2019, Secretary & Finance Manager at China Powerplus Ltd. from 2004 to 2007, Member-Supervisory Board at BIOTON SA, Auditor at Ernst & Young LLP, and Financial Controller-Greater China at Fullerton Healthcare Group Pte Ltd. from 2016 to 2018.
Education includes an undergraduate degree from Nanyang Technological University conferred in 2000.